Immunome, Inc.

NASDAQ:IMNM

8.84 (USD) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -292.963-106.806-36.896-24.711-17.837-10.444-7.845
Depreciation & Amortization 2.1020.7280.6310.7550.7550.6150.521
Deferred Income Tax 00-7.271-0.55.53800
Stock Based Compensation 15.7486.2235.3323.4480.6210.0140.011
Change In Working Capital 14.87411.9972.2432.778-1.2090.212-0.102
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 9.526-0.608-0.6771.780.5040.0750.146
Other Working Capital 5.34812.6052.920.998-1.7130.137-0.248
Other Non Cash Items 149.44580.297.2710.004-0.0020.0030.009
Operating Cash Flow -110.794-7.568-28.69-18.226-12.134-9.6-7.406
Investing Activities:
Investments In Property Plant And Equipment -7.173-0.831-0.248-0.079-0.586-0.233-0.228
Acquisitions Net 09.27600000
Purchases Of Investments -186.555-38.92900000
Sales Maturities Of Investments 155000000
Other Investing Activites -46.335000000
Investing Cash Flow -85.063-30.484-0.248-0.079-0.586-0.233-0.228
Financing Activities:
Debt Repayment 000-0.1130.0496.188-0.551
Common Stock Issued 250.0020.0340.03227.22544.854.6210
Common Stock Repurchased 00000-0.0350
Dividends Paid 0000000
Other Financing Activities 0116.3740.0320.6565.0444.5860
Financing Cash Flow 240.529116.4080.03227.76849.94310.774-0.551
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 44.67278.356-28.9069.46337.2230.941-8.185
Cash At End Of Period 143.45198.77920.42349.32939.8662.6431.702